About Sidharath Gupta

Sidharath’s passion for financial markets and love for words guided his way to become a financial writer. He began his career as an Equity Analyst researching stocks and preparing in-depth research reports. Sidharath is currently pursuing the CFA program to deepen his knowledge of financial analysis and investment strategies.

Sidharath’s daily coverage of the financial markets keeps him on top of key trends, with the goal of helping investors make well-informed decisions.


Recent Articles By Sidharath Gupta

: EBON |  News, Ratings, and Charts

Think Bitcoin Will Keep Pulling Back? 3 Cryptocurrency Stocks to Avoid

Bitcoin appears to have hit a speed bump. A tweet from Tesla (TSLA) CEO Elon Musk and some words of caution from Treasury Secretary Janet Yellen made investors nervous about the digital currency’s lofty valuation and profit-taking has aggressively began. Ebang International Holdings (EBON), CleanSpark (CLSK), and The9 Limited (NCTY) are three weak crypto players, but they are currently trading at lofty valuations. These stocks could witness a pullback if Bitcoin undergoes a correction.
: CLSK |  News, Ratings, and Charts

Is CleanSpark a Good Cryptocurrency Stock to Buy?

The price of bitcoin has surged dramatically over the past year. With continued growth and wider cryptocurrency adoption, new players have entered the Bitcoin mining business to capitalize on the impressive growth of cryptocurrencies. A case in point is CleanSpark (CLSK), an energy technology solution company that has recently entered the Bitcoin business with the acquisition of crypto mining company ATL Data Centers. Read on to find out if CLSK can capitalize as bitcoin surges to new highs.
: HEAR |  News, Ratings, and Charts

3 Top Cyclical Stocks to Buy for an Improving Economy

Cyclical stocks—the category of stocks most sensitive to macroeconomic conditions—have caught investors’ attention as widespread hopes for a sharp economic recovery powers the market’s latest run at record highs. A proposed federal stimulus package and accommodative monetary policy are expected to drive an economic recovery with help from a national COVID-19 vaccine program. As such, we think top-rated cyclical stocks Turtle Beach (HEAR), Big 5 Sporting Goods (BGFV), and Escalade (ESCA) are set to offer attractive returns as the economy normalizes this year.
: BBBY |  News, Ratings, and Charts

2 Recent Short Squeeze Stocks That Now are Attractively Valued

In recent weeks, many investors have been introduced to the short squeeze, a phenomenon that has sent shares of struggling businesses to sky-high levels due to a tug of war between institutional short sellers and retail investors. Recent short squeezes have caused dramatic losses for short sellers of Bed Bath & Beyond (BBBY) and AMC Networks (AMCX). But we think these two stocks could nonetheless deliver promising returns at current price levels. Read on for an explanation.
: VNQ |  News, Ratings, and Charts

3 ETFs to Buy as Real Estate Prices Rapidly Rise

The U.S. housing market has been red hot for some time due to low mortgage rates. However, many house hunters have been unable to purchase properties due to inflated asking prices. Because mortgage rates are rising now with the expectation of economic growth, we think it could be wise to bet on real estate ETFs such as Vanguard Real Estate ETF (VNQ), iShares U.S. Real Estate ETF (IYR), and Real Estate Select Sector SPDR Fund (XLRE), to capitalize on rising real estate prices.
: COST |  News, Ratings, and Charts

Costco vs. BJ's Wholesale: Which Stock is a Better Buy?

While most physical retailers have struggled to survive amid the COVID-19 pandemic due to nationwide lockdowns and increasing competition from e-commerce, retail customers’ have shifted to omnichannel fulfillment warehousing companies like Costco Wholesale Corporation (COST) and BJ's Wholesale Club Holdings (BJ) for essential commodities. Both players have expanded their offerings rapidly and focused on their online operations to support sales during the pandemic and to expand their customer bases. But which of these stocks is a better pick now? Let’s find out.
: AMZN |  News, Ratings, and Charts

Amazon vs. MercadoLibre: Which E-Commerce Stock is a Better Buy?

The e-commerce market has been soaring in part because coronavirus fears have kept shoppers locked away indoors for the past 10 months. Amazon.com (AMZN) and MercadoLibre (MELI) are two of the most innovative and fastest-growing e-commerce companies. They have generated hefty returns since the onset of the pandemic. However, as the world reverts to the “old normal” this year on the back of an anticipated economic recovery, e-commerce growth may slow. So, let’s find out which of these stocks is better positioned to deliver promising returns going forward.
: SHOP |  News, Ratings, and Charts

Is Shopify Still a Good Stock to Buy?

Online buying and selling accelerated amid the COVID-19 pandemic because it allowed consumers to fulfill many of their shopping needs remotely. Shopify (SHOP) is playing an important role for small businesses by helping them acquire a now vital online presence. As a result, shares of SHOP have surged nearly 170% over the past year. But can SHOP maintain its momentum? Read ahead to find out?
: LOW |  News, Ratings, and Charts

Lowe's is a Great Momentum Stock: Should You Buy?

The demand for home furnishings products for new homes or to transform existing living spaces into home offices has surged dramatically since the onset of the COVID-19 pandemic last year. As a result, shares of home improvement retailer Lowe’s Companies (LOW) have gained nearly 39% over the past year. Read ahead to learn whether LOW can maintain its momentum as the world retreats to the ‘old normal’ this year.
: CVS |  News, Ratings, and Charts

Are Investors Undervaluing CVS Health Right Now?

The COVID-19 pandemic has revealed the limitations of the world’s healthcare systems. As a corollary to this, it has also highlighted the importance of pharmacy-chains like CVS Health (CVS) in the U.S. After playing a key role in COVID-19 diagnostic tests, CVS is now involved in the administration of the biggest vaccination program in U.S. history. However, investors may not have rewarded the stock sufficiently or consistent with its sound financials and robust long-term prospects. Read ahead to learn whether CVS is a good addition to your portfolio at the current price level or a value trap.
Page generated in 1.2252 seconds.